How Levothyroxine Dose Is Calculated: Weight, Age, and Why You May Need Adjustments

Levothyroxine starting dose is roughly 1.6 mcg/kg/day for full replacement in otherwise healthy adults, lower in elderly or cardiac patients. After 6 weeks the TSH guides titration. Individual factors — age, sex, comorbidity, formulation, GI absorption, and pregnancy — commonly shift the final dose.

How the starting dose is calculated

For an otherwise healthy adult with overt primary hypothyroidism, the American Thyroid Association recommends a weight-based starting dose of about 1.6 mcg per kilogram of ideal body weight per day [C1]. A 70 kg adult would therefore start near 112 mcg/day, rounded to the nearest commercially available tablet strength (typically 100 or 112 mcg). The formula is a starting estimate, not the final answer — most patients need at least one adjustment based on the 6-week TSH.

The estimate is based on the daily T4 output of a healthy thyroid (about 100 mcg) scaled to body size, with the assumption that roughly 70–80% of an oral tablet is absorbed in the small intestine [C1][C2]. This is why ideal body weight, not total body weight, is preferred: fat mass does not contribute meaningfully to T4 turnover, and using total weight in patients with obesity overestimates the dose [C2].

Two categories of patients start lower than 1.6 mcg/kg/day [C1]:

• Adults over 60–65 typically start at 25–50 mcg/day and titrate upward every 4–6 weeks. Aging slows T4 clearance and increases sensitivity, so the final maintenance dose averages 1.0–1.2 mcg/kg/day.
• Patients with known coronary artery disease or atrial fibrillation start at 12.5–25 mcg/day to avoid precipitating angina or arrhythmia, with cautious upward titration under cardiology guidance.

Clinical scenarios that change the calculation

The 1.6 mcg/kg/day rule applies to outpatient primary hypothyroidism. Several other scenarios use different starting points [C1][C2]:

• Subclinical hypothyroidism (mildly elevated TSH, normal free T4) often does not require full replacement. When treatment is offered, doses are usually 25–75 mcg/day rather than weight-based, with the goal of normalizing TSH without over-replacement [C1]. In adults over 80, recent trials show no symptomatic or cardiovascular benefit from treating mild subclinical disease, so the threshold to start is higher [C4][C5].
• Post-thyroidectomy or post-radioactive iodine ablation, the gland is gone and full replacement is required from day one. Dose modeling studies show 1.7–1.8 mcg/kg/day is often closer to the right starting point than 1.6 mcg/kg/day in athyreotic patients, because there is no residual endogenous T4 [C7].
• Central hypothyroidism (pituitary failure rather than primary gland failure) is dosed against free T4, not TSH — because TSH itself is unreliable. Most patients still land near 1.6 mcg/kg/day, but titration is guided by keeping free T4 in the upper half of the reference range [C1].
• Pregnancy increases levothyroxine requirements by roughly 30–50% starting in the first trimester, driven by higher estrogen, expanded plasma volume, and placental deiodination of T4 [C3]. Many endocrinologists pre-instruct patients to add two extra doses per week as soon as pregnancy is confirmed, then adjust based on TSH every 4 weeks.

Why patients at the same weight need different doses

Weight is the largest single predictor of dose, but it is not the only one. Caron's 2022 review summarizes the factors that shift dose at the same weight [C2]:

• Age and sex. Older adults and women tend to need slightly lower per-kg doses; younger men tend to need slightly higher.
• Cause of hypothyroidism. Patients with no residual thyroid tissue (post-surgery, post-ablation) need more per kg than patients with Hashimoto's, where some endogenous T4 production may persist for years [C2][C7].
• Coexisting GI conditions. Celiac disease, atrophic gastritis, H. pylori, lactose intolerance, and chronic proton pump inhibitor use all reduce absorption and raise the dose required to reach the same TSH [C2].
• Drug interactions. Iron, calcium, fiber supplements, certain antacids, bile acid sequestrants, and estrogens all reduce absorption or increase clearance, so concurrent use changes the maintenance dose [C2].
• Formulation. Liquid and soft-gel preparations bypass the dissolution step required for tablets and are less affected by gastric pH; some patients on tablets need a slightly higher dose than they would on a liquid form [C2].

This is why two patients of identical weight commonly end up 25–50 mcg apart, and why your endocrinologist will titrate based on your own TSH rather than copying anyone else's dose.

Why the 6-week TSH wait matters

After any dose change, TSH takes about 6 weeks to fully reflect the new steady state, because thyroxine has a half-life of about 7 days and the pituitary feedback loop adjusts slowly [C1]. Checking TSH at 2 or 3 weeks usually shows a moving target — a value that has not yet stabilized — and can prompt unnecessary dose changes.

The standard cadence is:

1. Start the calculated dose (or 25–50 mcg in elderly/cardiac patients).
2. Recheck TSH at 6 weeks, taken consistently in the morning before the levothyroxine dose [C1].
3. Adjust by 12.5–25 mcg if TSH is outside the target range, then wait another 6 weeks.
4. Repeat until TSH is stable in the target range (usually 0.5–2.5 mIU/L for symptomatic patients).
5. Annual TSH once stable, sooner if weight, pregnancy, or other medications change.

Most patients reach a stable dose within 3–4 titration cycles [C1][C2].

What does NOT change the calculation

Several heavily marketed ideas have no role in dose calculation [C1][C6][C8]:

• "Optimal" doses based on symptoms alone, ignoring TSH. Symptom-only dosing risks chronic over-replacement, which independently raises the risk of atrial fibrillation, osteoporosis, and cardiovascular events [C8].
• Adding T3 routinely. The 2014 ATA guideline reserves combination therapy for selected patients still symptomatic at a normalized TSH — it does not change the levothyroxine starting calculation [C1].
• Switching to desiccated thyroid extract by default. First-line treatment remains synthetic levothyroxine; desiccated thyroid is not equivalent on a microgram-for-microgram basis and complicates dose tracking [C1].
• Brand-vs-generic without recheck. The FDA considers generic and brand levothyroxine bioequivalent, but the ATA, AACE, and Endocrine Society have documented TSH shifts in some patients after a pharmacy substitution — so any product change calls for a 6-week TSH recheck, not a different calculation [C6]. See our generic-vs-brand-levothyroxine article.

Practical guidelines

1. For a healthy adult, expect a starting dose near 1.6 mcg/kg/day of ideal body weight. A 70 kg patient lands near 112 mcg/day [C1].
2. If you are over 60 or have heart disease, expect to start at 25–50 mcg and titrate slowly every 4–6 weeks [C1].
3. Recheck TSH at 6 weeks after any dose change — earlier values do not reflect steady state [C1].
4. Tell your endocrinologist about any new medications, supplements, or pregnancy. Iron, calcium, fiber, PPIs, and estrogen all shift the dose required [C2][C3].
5. If your pharmacy switches your brand or formulation, request a 6-week TSH recheck to confirm you are still in range [C6].
6. Annual TSH once stable. Pregnancy, large weight changes, GI surgery, or new medications warrant earlier rechecks [C1][C2].

Frequently asked questions

Why didn't my doctor just use 1.6 mcg/kg from the start? Because the calculation overshoots in older adults and in anyone with cardiac risk. Starting at 25–50 mcg and titrating up is safer than starting at the full calculated dose and risking arrhythmia [C1][C5].

Is the dose calculated on total weight or ideal weight? Ideal body weight, in most guidelines. Total weight overestimates the dose in patients with obesity, because adipose tissue does not contribute meaningfully to T4 turnover [C2].

Why do I need more levothyroxine in pregnancy? Estrogen raises thyroid-binding globulin, the placenta inactivates some T4, and plasma volume expands — together these increase the dose required by 30–50% starting in the first trimester [C3]. Your endocrinologist will recheck TSH every 4 weeks during pregnancy.

Will switching from a brand to a generic change my dose? The FDA considers them bioequivalent, but the ATA, AACE, and Endocrine Society recommend a TSH recheck 6 weeks after any product switch because some patients show a measurable shift [C6].

Can my dose ever go down? Yes. Weight loss, pregnancy ending, stopping interfering medications (iron, calcium, PPIs), or recovery of residual thyroid function in some Hashimoto's patients can all reduce the requirement. Over-replacement raises cardiac and bone risk, so dose reductions are part of normal maintenance [C2][C8].

Bottom line

Levothyroxine dose starts from a weight-based calculation — about 1.6 mcg/kg/day of ideal body weight for healthy adults, lower in elderly or cardiac patients [C1]. The 6-week TSH guides titration to a personal maintenance dose [C1]. Age, sex, cause of hypothyroidism, formulation, GI absorption, drug interactions, and pregnancy all shift the dose at the same weight — which is why your endocrinologist will adjust based on your own TSH rather than a fixed formula [C2][C3][C7]. Over-replacement carries real cardiac and bone risk, so the goal is the lowest dose that keeps TSH in range — not the highest dose that makes symptoms disappear [C6][C8].